Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition
暂无分享,去创建一个
A. Jablensky | F. Waters | M. Dragovic | L. Kalaydjieva | B. Morar | D. Chandler | B Morar | M Dragović | F A V Waters | D Chandler | L Kalaydjieva | A Jablensky | Flavie Waters | David Chandler
[1] C. W. Harley,et al. Calcineurin inhibition eliminates the normal inverted U curve, enhances acquisition and prolongs memory in a mammalian 3′-5′-cyclic AMP–dependent learning paradigm , 2009, Neuroscience.
[2] K. Schneider. Clinical psychopathology. (Trans. by M. W. Hamilton), 5th ed. , 1959 .
[3] M. Buchsbaum,et al. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls , 1995, Schizophrenia Research.
[4] Paul J. Harrison,et al. Molecular Cloning of a Brain-specific, Developmentally Regulated Neuregulin 1 (NRG1) Isoform and Identification of a Functional Promoter Variant Associated with Schizophrenia*♦ , 2007, Journal of Biological Chemistry.
[5] Douglas L Falls,et al. Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.
[6] A. Jablensky,et al. Subtyping schizophrenia: implications for genetic research , 2006, Molecular Psychiatry.
[7] S. Batalov,et al. A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Sliwkowski,et al. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. McGinnis,et al. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia , 2007 .
[10] P. van Eerdewegh,et al. Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. , 2006, The American journal of psychiatry.
[11] J. Badcock,et al. Neuropsychological Functioning in Schizophrenia Patients with First-Rank (Passivity) Symptoms , 2009, Psychopathology.
[12] P. M. Guffin,et al. The diagnostic interview for psychoses (DIP) : development, reliability and applications , 2006 .
[13] J. McGrath,et al. Familiality of novel factorial dimensions of schizophrenia. , 2009, Archives of general psychiatry.
[14] K. Nuechterlein. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. , 1983, Journal of abnormal psychology.
[15] Kenneth G. Manton,et al. Statistical applications using fuzzy sets , 1994 .
[16] J. McGrath,et al. Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. , 2003, American journal of human genetics.
[17] J. McGrath,et al. Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. , 2009, American journal of human genetics.
[18] Luba Kalaydjieva,et al. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. , 2005, American journal of human genetics.
[19] Graham V. Williams,et al. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory , 2007, Nature Neuroscience.
[20] H. Stefánsson,et al. Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.
[21] A. Buonanno,et al. Neuregulin‐2 is developmentally regulated and targeted to dendrites of central neurons , 2004, The Journal of comparative neurology.
[22] S. Tsai,et al. Neuregulin 3 Genetic Variations and Susceptibility to Schizophrenia in a Chinese Population , 2008, Biological Psychiatry.
[23] S. Selleck,et al. Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities. , 2007, American journal of human genetics.
[24] Daniel R. Weinberger,et al. Neuregulin 1 Transcripts Are Differentially Expressed in Schizophrenia and Regulated by 5′ SNPs Associated With the Disease , 2006 .
[25] M. Egan,et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Carpenter,et al. ErbB-4: mechanism of action and biology. , 2003, Experimental cell research.
[27] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[28] T. Brugha,et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. , 1990, Archives of general psychiatry.
[29] Gonçalo R Abecasis,et al. Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans , 2009, Proceedings of the National Academy of Sciences.
[30] Raquel E Gur,et al. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. , 2006, Schizophrenia bulletin.
[31] A. Ferrer-Montiel,et al. Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival , 2006, Journal of Cell Science.